Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / VPIX Medical, Inc.

Approvalsdevice cleared16 Oct 2026

VPIX Medical, Inc.

16 Oct 2026: Device cleared · cCeLL - In vivo. Recorded in the openFDA device 510(k) data.

View the source record

Decided
16 Oct 2026
Device
cCeLL - In vivo
Specialty
Neurology
Country
South Korea
Location
Daejeon
Clearance type
Traditional
510(k) number
K260315
Submitted
2026-01-30
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at VPIX Medical, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for VPIX Medical, Inc. in our registers.

More in Neurology

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.